Scranton P E, Hasiba U, Gorenc T J
JAMA. 1979 May 11;241(19):2028-30.
Any hemorrhage in a hemophilic patient must be regarded as a serious problem. A small percentage of hemophiliacs have an inhibitor that will destroy factor VIII or IX clotting activity, thus making control even more difficult. This occurrence predisposes these patients to joint contractures and deformities secondary to repeated, uncontrolled hemorrhages into muscle compartments and joints. Patients with an inhibitor must, therefore, be recognized, and any bleeding should be treated as an emergency. A combined treatment protocol has been developed by the hematology and orthopedic departments in a effort to achieve early hemorrhage control and prevent subsequent deformity.
血友病患者的任何出血都必须被视为严重问题。一小部分血友病患者有一种抑制剂,它会破坏凝血因子VIII或IX的凝血活性,从而使病情控制更加困难。这种情况使这些患者更容易因反复、不受控制地出血进入肌肉间隙和关节而导致关节挛缩和畸形。因此,必须识别出有抑制剂的患者,任何出血都应作为紧急情况处理。血液科和骨科已经制定了联合治疗方案,以努力实现早期出血控制并预防后续畸形。